NEW YORK CITY, NY / / June 10, 2026 / Emerging Growth Research today announced the release of its Initiation Report on ...
Coya is currently conducting the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ( ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する